Equity
€253,498 ▲ 77.3%
Equity rose in 2025 from €142,994 to €253,498.
Docteur Anouk DUFRANE
Lifetime
3 annual accounts with figures on one time axispeak €179,287 (2025)
€179,287▲ 18.0%
peak €110,504 (2025)
€110,504▲ 33.9%
peak €253,498 (2025)
€253,498▲ 77.3%
€259,734▲ 1.2%
Board1 name since 2022
1 directorDUFRANE,Anouk
Documentsfilings and deeds
30-06-202631 days before the deadline
2025micro format
Gross margin from €151,968 to €179,287Result from €82,535 to €110,504Equity from €142,994 to €253,498Cash from €92,387 to €147,019
Key points
from the 2025 annual accountsChecked score
95
Excellent
Financially stronger than 61% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 24,192 companies (NACE 86, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: < 0.1%
01-2025: < 0.1%● unchanged vs 12-2024
02-2025: < 0.1%● unchanged vs 01-2025
03-2025: 0.1%▲ +0.1 percentage points vs 02-2025
04-2025: 0.1%● unchanged vs 03-2025
05-2025: 0.1%● unchanged vs 04-2025
06-2025: 0.1%● unchanged vs 05-2025
07-2025: 0.1%● unchanged vs 06-2025
08-2025: 0.1%● unchanged vs 07-2025
09-2025: 0.2%▲ +0.1 percentage points vs 08-2025
10-2025: 0.4%▲ +0.2 percentage points vs 09-2025highest value
11-2025: < 0.1%▼ -0.4 percentage points vs 10-2025
12-2025: < 0.1%● unchanged vs 11-2025
01-2026: < 0.1%● unchanged vs 12-2025
02-2026: < 0.1%● unchanged vs 01-2026
03-2026: 0.1%▲ +0.1 percentage points vs 02-2026
04-2026: 0.1%● unchanged vs 03-2026
05-2026: 0.1%● unchanged vs 04-2026
06-2026: 0.1%● unchanged vs 05-2026
07-2026: < 0.1%▼ -0.1 percentage points vs 06-2026
08-2026: < 0.1%● unchanged vs 07-2026
09-2026: < 0.1%● unchanged vs 08-2026lowest value
10-2026: < 0.1%● unchanged vs 09-2026lowest value
11-2026: < 0.1%● unchanged vs 10-2026lowest value
Financial strengthStrong
Score breakdown
raises risk
2 of the last 3 accounts late
lowers risk
Sector: Human health activities (NACE 86)
Liquidity: current ratio 3.29, cash €147,019
Founded in 2022
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 39% of them on solvency, 61% on liquidity, 55% on profitability and 86% on growth.
The bankruptcy probability was computed on 10-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 3,127 companies had the same profile as Docteur Anouk DUFRANE has now. Each dot stands for 8 companies, two years later.
97.2%
were still trading
1.9%
stopped another way
0.8%
went bankrupt
That fits the bankruptcy probability of Docteur Anouk DUFRANE itself: < 0.1% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 3,127 companies, not a prediction for Docteur Anouk DUFRANE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €24,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 3.29 (2.82 in 2024), above the usual 1.5. Short-term debt is 20.2% and cash 28.6% of total assets. However, 50.6% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.
NBB · 3 filingsDeviation from the deadline
2025
31 days early
2024
61 days late
2023
58 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 3 accounts on average 29 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 28 September (3 of the last 3 accounts filed within 90 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
10-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0795123351
Incorporation
Founding capital of €10,000, 100 shares · Founder: DUFRANE, Anouk (comparant,fondateur) · Appointment: DUFRANE, Anouk (director) · published on 22-12-2022 · Gazette deed
First establishment
Hameau de Poningue 110, Hensies
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| Docteur Anouk DUFRANE Hensies | €513,232 | €179,287 | 49.4% | - |
| DOKTER ANNE JANSSEN, RADIOLOGIE Herk-de-Stad | €518,694 | €183,027 | 31.8% | - |
| Dr. Evy Lenaerts Antwerp | €508,721 | €186,021 | 99.6% | - |
| Dr. EVO Baarle-Hertog | €506,772 | €202,046 | 89.1% | - |
| Dr SIMON M-F Hannut | €485,839 | €160,242 | 60.8% | - |
| DR. POELMANS PHILIP Alken | €467,701 | €200,643 | 63.8% | - |
| Dr. Paquay Elisa Peer | €561,223 | €160,747 | 93.3% | - |
These companies have the same main activity as Docteur Anouk DUFRANE: general medical practice (NACE 86210). They are comparable in size and age: total assets between €468,000 and €561,000, founded between 2022 and 2023.
Official details
Source: KBO- Status
- Active since 20-12-2022Normal situation
- Activity
- General medical practiceNACE 86210
- Establishment unit
- 2.340.995.5257350 Hensies, since 20-12-2022
- Financial year end
- 31 December
- Peppol
- Reachable since 22-12-2025
Annual accounts 2025
- €513,232▲ 28.4%
- Filing
- Filed on 30-06-2026, 31 days before the end of the filing period
Insights on Docteur Anouk DUFRANE
Docteur Anouk DUFRANE files the micro format. That format states no turnover. The gross margin rose from €110,772 in 2023 to €179,287 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Docteur Anouk DUFRANE
- What is the company number of Docteur Anouk DUFRANE?
- The company number of Docteur Anouk DUFRANE is 0795.123.351. The VAT number is the same number with BE in front: BE 0795.123.351.
- Where is Docteur Anouk DUFRANE based?
- The registered office is at Hameau de Poningue 110, 7350 Hensies.Company details
- What does Docteur Anouk DUFRANE do?
- According to the KBO register, the main activity is general medical practice (NACE 86210).
- What is the legal form of Docteur Anouk DUFRANE?
- Docteur Anouk DUFRANE is a private limited company (BV).
- When was Docteur Anouk DUFRANE founded?
- Docteur Anouk DUFRANE was founded on 20-12-2022.
- Is Docteur Anouk DUFRANE still active?
- Yes, Docteur Anouk DUFRANE is an active enterprise in the KBO register.
- What is the turnover of Docteur Anouk DUFRANE?
- The turnover in financial year 2025 is ≈ €360,000. This figure is estimated from the gross margin of €179,287 and 65 comparable companies (NACE 862). It probably lies between €270,000 and €450,000.Financials
- Is Docteur Anouk DUFRANE profitable?
- In financial year 2025, Docteur Anouk DUFRANE made a profit of €110,504.
- Where can I find the annual accounts of Docteur Anouk DUFRANE?
- Docteur Anouk DUFRANE filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Docteur Anouk DUFRANE due?
- Docteur Anouk DUFRANE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies Compare this company with its sector.Sector benchmark
See how customers, suppliers and banks see your own company and what to improve first.